April 29, 2009
Are drug companies putting money where their mouths are?
In a new trend, the pharmaceutical industry is offering what the NY Times calls, “money-back guarantees,” essentially paying for treatments if their drug fails.
For instance, the makers of the osteoporosis drug Actonel will pay “$30,000 for a hip fracture . . and $6,000 for a wrist [...]
Read the full article →
April 19, 2009
Here are some of the more interesting comments readers have left recently.
1. Manalive on quality measures:It is almost always a leap of faith to apply evidence-based guidelines to the frail elderly, to patients with many medical problems, to alcoholics, to the poorly insured — in short, to a large percentage of my practice. Accordingly, I [...]
Read the full article →